My PCR
Create Account
Logo PCR

18 May 2022

Stents, scaffolds and DCB

The current role of paclitaxel DCB in PCI

Sponsored by Fondazione Ricerca e Innovazione Cardiovascolare, with the support of Biotronik, Medtronic, and B.Braun Melsungen AG

Anchorperson: B. Cortese
Moderator: R. Byrne
SHOW MORE

Summary

Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on the long term.

Learning Objectives

  • To understand the role of paclitaxel DCB in modern era interventional cardiology
  • To learn how to correctly prepare the lesion and obtain the best from this technology on the long term
  • To understand the differences and advantages versus DES
  • To understand the role of blended therapies in CLS
Related Content
Share your work at PCR-CIT China Chengdu Valves 2025 How to avoid using a new balloon for trapping? Preventing distal particles embolization after DCB angioplasty
Recommended for you
AICT-AsiaPCR: what's in store this year? What's the best way to reduce the cost of your #AictPCR badge? AICT-AsiaPCR: Call for Submissions is now open